New triglyceride-lowering therapy Olezarsen significantly reduces severe hypertriglyceridemia and acute pancreatitis risk, offering hope for patients.
Nicholas Marston, MD, MPH
Advertisement
Articles by Nicholas Marston, MD, MPH
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
New Enlicitide Decanoate Data Show Significant LDL-C Reductions in At-Risk Patients
2
Newly Approved Specialty Drugs Advance Care for Inflammatory and Autoimmune Diseases
3
FDA Approves Tarlatamab-Dlle to Treat Adults With Extensive Stage Small Cell Lung Cancer
4
Twice-Yearly Depemokimab Improves Peak Expiratory Flow and Asthma Symptoms
5
